Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience

MARIA IDA AMABILE, MASSIMO MONTI, RAFFAELE MEROLA, FEDERICO FRUSONE, VALERIO D'ORAZI and VITTORIO PASTA
Anticancer Research February 2016, 36 (2) 779-783;
MARIA IDA AMABILE
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: marida.amabile{at}gmail.com
MASSIMO MONTI
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFFAELE MEROLA
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FEDERICO FRUSONE
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VALERIO D'ORAZI
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
2Department of General Microsurgery and Hand Surgery, Fabia Mater Hospital, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VITTORIO PASTA
1Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Nipple-sparing mastectomy (NSM) is a recognized treatment for selected patients with breast cancer (BC). Our study aimed to analyze 7 years' experience in NSM and breast reconstruction for patients with preoperative diagnosis of non-invasive BC. Patients and Methods: All NSMs with breast reconstruction, performed between January 2007 and December 2013 in patients with preoperative diagnosis of non-invasive BC, were considered. Results: Thirty-five NSMs were performed, 23 cases confirming the diagnosis of non-invasive BC, and in 12 patients it also resulted in findings of an invasive component. Patients were stratified into two groups: breast reconstruction was performed i) with silicone definitive implant, ii) with a temporary breast tissue expander. An invasive component at the postoperative histological examination was significantly associated with tissue expander reconstruction (p=0.03). Conclusion: In selected cases, NSM is a valid and safe procedure. Further critical evaluations are required for more evidence on this argument.

  • Nipple-sparing mastectomy
  • non-invasive breast cancer
  • breast reconstruction

The validity of a surgically-conservative therapy of breast cancer (BC) is internationally recognized (1-3). A patient's psychological distress after surgical treatment for BC has markedly decreased since the radical surgery shifted to breast conservation and immediate reconstruction (4). Skin-sparing mastectomy (SSM) with nipple-areola complex (NAC) excision and immediate breast reconstruction is a validated technique for the type of BC not allowing breast-conservative surgery, providing the best cosmetic result (5, 6). Success with SSM has paved the way for nipple-sparing mastectomy (NSM) as a valid alternative treatment to SSM and conventional mastectomy in selected patients (6-8).

NSM represents an ideal surgical treatment when it is applicable (7-9). Breast reconstruction after NSM is possible with satisfactory esthetic results, few complications and no decrease in the quality of life (10, 11). The entire breast skin envelope and the NAC remain preserved, allowing an immediate reconstruction and avoiding creation of a new NAC (8, 11, 12). In addition, patient psychological effects are improved (13).

Indications for NSM remain controversial (8,13), especially in those patients affected by non-invasive BC. This type of BC can be locally diffused, not well-evaluable at the preoperative assessment and the neoplastic tissue can be adjacent to the NAC, with a risk of recurrence (14).

Despite numerous studies on the validity of NSM procedures and immediate reconstruction (8, 15), the role of NSM in the treatment of non-invasive BC and the decision on the type of subsequent reconstruction are controversially discussed (16). Our retrospective study aimed to analyze around 7 years' experience in the treatment of patients with preoperative diagnosis of non-invasive BC who underwent NSM and subsequent immediate breast reconstruction with definitive breast implant or 2-step breast reconstruction, firstly with a saline-filled temporary expander and in a second step with breast definitive silicone implant. We evaluated our complications, outcomes and cancer recurrence rate to delineate internal guidelines.

Materials and Methods

Patients. A retrospective study was conducted considering patients with BC who underwent NSM in the period between January 2007 and December 2013 at the Department of Surgical Sciences, Sapienza University of Rome, Italy. According to the ethical standards of our Institution and of the Helsinki Declaration of 1975, revised in 2000, patients with preoperative diagnosis of non-invasive BC and treated with NSM were considered. Patients with a breast-related cancer antigen (BRCA) gene mutation were also included. All patients were studied with radiological preoperative and clinical examinations. The preoperative diagnosis was obtained with percutaneous core-needle biopsy of the detected lesion. Patients were candidates for NSM if no infiltration of the NAC at imaging and no pathological nipple discharge were documented. All the patients were previously informed about the purpose and the possible complications and outcome of the nipple-sparing procedure, and their informed consent was obtained.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patient characteristics and factors associated with breast reconstruction techniques after nipple-sparing mastectomy.

Surgical technical notes. The operations were performed using a radial incision (Figure 1), a breast-fold incision or a vertical pattern incision to allow skin-reducing procedure and correct breast ptosis. The NSM procedure was performed removing all visible breast tissue, as well as the glandular component located immediately behind the NAC. In all cases, an intraoperative histological exam with frozen sections of the areolar undersurface tissue was performed. Axillary lymph node staging was conducted with sentinel node biopsy procedure or radical axillary dissections depending on tumor size and definitive histological examination (17, 18).

The breast reconstruction was performed directly with breast silicone definitive implants or with breast tissue expanders, which required a second subsequent reconstructive step.

Assessment. We evaluated short-term postoperative complications assessment. In patients with a follow-up period longer than 5 years, it was possible to carry out a long-term evaluation including study recurrences and their management, and the patient's opinion of areolar sensitivity.

Statistical analysis. Patient characteristics were described using the mean±standard deviation for continuous normally distributed variables and percentage for dichotomous variables. Variables that were not normally distributed were described using the median with 25th and 75th percentile. Where applicable, Chi-square test and Student's t-test (two-sample) were used to calculate the p-values. A p-value lower than 0.05 was considered statistically significant.

Results

In the period between January 2007 and December 2013, 35 NSMs with breast reconstruction were performed in 34 patients with a preoperative diagnosis of non-invasive BC, obtained with percutaneous core-needle biopsy, at the Department of Surgical Sciences, Sapienza University of Rome, Italy. One patient presented a bilateral breast tumor hence she underwent bilateral NSM. Patient characteristics are reported in Table I.

Twenty-one tumors were located in the right breast, 14 tumors on the left side. At the postoperative histological examination, the definitive diagnosis of non-invasive BC was confirmed in 23 cases, and in 12 cases, an invasive component was also found. The mean size of the tumors was 15 mm (10-53 mm), including multifocal and multicentral type, and tumor recurrences.

Breast reconstructions were performed with saline-filled tissue expanders in 19 cases and with silicone definitive breast implant in 16 cases.

In all cases, an intraoperative histological examination with frozen sections of the under-areola tissue was performed. Only one of the NSMs was converted into SSM during the intraoperative time, based on the histological analysis that was positive for the presence of tumor in the areolar flap's undersurface.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

a: Monolateral nipple-sparing mastectomy with radial incision. b: Bilateral nipple-sparing mastectomy. Both images were taken three months after surgery.

The sentinel node biopsy procedure was performed in the 12 patients with an invasive component, and in the cases of extended multifocal form of non invasive BC. In five patients, the sentinel lymph node was found to have a macro-metastasis and subsequently axillary dissection was performed, despite the preoperative imaging not revealing the suspicion of a lymph node lesion.

Only in one case the breast tissue expander was removed because of a peri-implant infection occurring in the postoperative period that caused necrosis and subsequent loss of the NAC. The patient was obese and a significant ptosis was detected in the preoperative assessment.

We stratified the patients into two groups, considering the breast reconstruction modality performed: one group in which the breast reconstruction was directly performed with silicone definitive implant, and a second group in which a breast tissue expander was initially positioned and the reconstruction was completed in a second step by replacement with a breast silicone implant to evaluate potential differences in complications, outcomes and cancer recurrence rate between the two groups

In univariate analysis, the two groups did not differ for any of the considered clinical parameters, except for the parameter “report of carcinoma invasive component at the postoperative histological examination”, which was significantly associated with breast postoperative reconstruction using tissue expander (p=0.03) (Table I).

The mean follow-up postoperative period was 4.2 years (range=1-7 years). One patient with BCRA mutation experienced a pectoral skin metastasis 1 year after the NSM and subsequently, after 1 more year, a lung metastasis. One patient treated with NSM for a recurrence of breast tumor experienced a lung metastasis 2 years after the NSM. No recurrence at the NAC was documented. None of the patients self-reported as having sensitivity in the preserved NAC.

Discussion

The oncological validity of NSM is still controversial, mainly marked by the possibility of residual tumor cells in the NAC region and in the retro-areolar tissue after surgery (7, 11). However, there are studies that support the validity of conservative therapy and of NSM (1, 16). First of all, primary radical mastectomy does not improve survival rates (1). Randomized, prospective studies with extended follow-up periods documented no differences in overall survival in patients belonging to the mastectomy group whose NAC was removed compared to patients belonging to the tumorectomy group whose NAC was retained (14, 15).

In addition, studies with a small number of patients and a relatively short follow-up period found a low rate of recurrence within the NAC during 5 years of follow-up, suggesting that NSM is feasible in the setting of BC treatment, following precise indications, and helping to design further larger prospective studies to assess the oncological safety of NSM (19, 20).

There are several advantages of NSM. The psychological stress for the patient after breast amputation is markedly reduced. NSM allows breast prosthesis-based reconstruction in one single surgery, facilitating symmetry of the breasts. The breast skin envelope and the NAC are preserved, obtaining better cosmetic results than radical mastectomy, considering that the NAC is more difficult to reconstruct compared to the breast mound (11, 16).

For this reason, we retrospectively evaluated our experience in NSM and breast reconstruction modalities. We performed histological evaluation with frozen sections of the areolar undersurface tissue during each NSM procedure because it did not modify the surgical time. During the intraoperative time, waiting for the intraoperative histological result, we continued with the breast reconstruction. For our series of patients, one intraoperative resection of the NAC was performed because the frozen histological analysis was positive for neoplastic cells in the undersurface of the areolar flap. In the other cases, the definitive histological examination confirmed the negative intraoperative evaluation and no secondary NAC resection for tumor was performed. As short-term complication, necrosis of the NAC due to periprosthetic infection occurred in one patient and consequently the NAC was secondarily excised. Regardless of the type of breast reconstruction pursued, no Mondor's disease was observed during the postoperative assessment, as described in other cases (21).

No recurrence of the tumor in the nipple area has been observed during the follow-up time in any patient of our cohort, although the mean follow-up period was 4.2 years, with a minimum of 1 year and maximum of around 7 years.

Periareolar incision has been described to be significantly associated with secondary necrosis of the NAC (11, 20, 22). In our series, no periareolar incisions were performed. Rarely did we choose a breast-fold incision, mainly performed during the first patients treated with NSM, because we saw that it could not ensure a complete glandular resection, especially at the level of the axillary extension. We preferred radial incision, which allows more wide control of the operative area and easy and rapid access to the axillary region when necessary.

At our clinical Unit, the indication for NSM follows several principles. The distance of the detected lesion from the NAC has to be 2 cm or more. An adequate preoperative evaluation is fundamental in order to investigate if hematic or abnormal nipple discharge and NAC or skin retraction are present, conditions that represent a contraindication for NSM (23). Moreover, we performed NSM according to tumor size in relation to the breast volume. In our series, the mean dimension of the tumor was 15 mm. Multifocal and multicentral tumor, and tumor recurrence after breast conservative surgery were considered. In small or small-to-medium breasts, the conservative excision of tumors of size around 2 cm can distort the original breast shape with unsatisfactory results from a cosmetic point of view. This suggested that in these cases it is worthwhile performing NSM and reconstruction in order to obtain better cosmetic results. This indication should not be considered for other types of BC such as sarcoma, although of the same size (24, 25).

We stratified the patients into two groups according to the breast reconstruction modality performed. We retrospectively analyzed the data discovering interestingly that breast reconstruction with tissue expander was significantly associated with the presence of an invasive carcinoma component at the postoperative histological examination. Evaluating the patients whose breasts were reconstructed with breast expander, the choice to perform the procedure in that way was driven by the suspicion at the preoperative imaging examinations of a possible invasive or microinvasive component of the BC.

In cases of non-invasive carcinoma, the location of the tumor can be more diffuse than the size obtained at the radiological examinations and more adjacent to the NAC, with a major risk of there being an invasive component of the tumor (2, 14), and with a long-term risk of local recurrence (11, 14).

Investigating our series of patients, we document that we strongly decided for breast reconstruction with tissue expander when the preoperative imaging showed lesions such as those suspicious for a possible invasive component of the tumor, confirming the data reviewed in other studies (16).

Conclusion

NSM is a valid alternative to SSM in selected cases and a procedure that allows better esthetic results compared to conventional mastectomy, without modifying the patient's overall survival.

Our retrospective study, although with the methodological limitations of a heterogeneous and limited series of patients with a mean follow-up period no longer than 4 years, documents that this proposed technique is valid and safe if performed selectively according to indications, but more observations are required for further critical evaluation.

Footnotes

  • Conflicts of Interest

    No conflicts of interest to disclose.

  • Received December 7, 2015.
  • Revision received January 15, 2016.
  • Accepted January 19, 2016.
  • Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Veronesi U,
    2. Cascinelli N,
    3. Mariani L,
    4. Greco M,
    5. Saccozzi R,
    6. Luini A,
    7. Aguilar M,
    8. Marubini E
    : Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347: 1227-1232, 2002.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Amabile MI,
    2. Mazouni C,
    3. Guimond C,
    4. Sarfati B,
    5. Leymarie N,
    6. Cloutier AS,
    7. Bentivegna E,
    8. Garbay JR,
    9. Kolb F,
    10. Rimareix F
    : Factors predictive of re-excision after oncoplastic breast-conserving surgery. Anticancer Res 35: 4229-4234, 2015.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Pasta V,
    2. Sottile D,
    3. Urciuoli P,
    4. Del Vecchio L,
    5. Custureri F
    : Rare chondrosarcoma of the breast treated with quadrantectomy instead of mastectomy: A case report. Oncol Lett 9: 1116-1120, 2015.
    OpenUrlPubMed
  4. ↵
    1. Zurrida S,
    2. Bassi F,
    3. Arnone P,
    4. Martella S,
    5. Del Castillo A,
    6. Ribeiro Martini R,
    7. Semenkiw ME,
    8. Caldarella P
    : The changing face of mastectomy (from mutilation to aid to breast reconstruction). Int J Surg Oncol 2011: 980158. doi: 10.1155/2011/980158, 2011.
    OpenUrlPubMed
  5. ↵
    1. Patani N,
    2. Mokbel K
    : Oncological and aesthetic considerations of skin-sparing mastectomy. Breast Cancer Res Treat 111: 391-403, 2008.
    OpenUrlPubMed
  6. ↵
    1. Rusby JE,
    2. Brachtel EF,
    3. Othus M,
    4. Michaelson JS,
    5. Koerner FC,
    6. Smith BL
    . Development and validation of a model predictive of occult nipple involvement in women undergoing mastectomy. Br J Surg 95: 1356-1361, 2008.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Coopey SB,
    2. Tang R,
    3. Lei L,
    4. Freer PE,
    5. Kansal K,
    6. Colwell AS,
    7. Gadd MA,
    8. Specht MC,
    9. Austen WG Jr.,
    10. Smith BL
    : Increasing eligibility for nipple-sparing mastectomy. Ann Surg Oncol 20: 3218-3222, 2013.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Shimo A,
    2. Tsugawa K,
    3. Tsuchiya S,
    4. Yoshie R,
    5. Tsuchiya K,
    6. Uejima T,
    7. Kojima Y,
    8. Shimo A,
    9. Hayami R,
    10. Nishikawa T,
    11. Yabuki Y,
    12. Kawamoto H,
    13. Sudo A,
    14. Fukuda M,
    15. Kanemaki Y,
    16. Maeda I
    : Oncologic outcomes and technical considerations of nipple-sparing mastectomies in breast cancer: experience of 425 cases from a single institution. Breast Cancer doi:10.1007/s12282-015-0651-6, 2015.
  9. ↵
    1. Maxwell GP,
    2. Storm-Dickerson T,
    3. Whitworth P,
    4. Rubano C,
    5. Gabriel A
    : Advances in nipple-sparing mastectomy: oncological safety and incision selection. Aesth Surg J 31: 310-319, 2011.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Shi A,
    2. Wu D,
    3. Li X,
    4. Zhang S,
    5. Li S,
    6. Xu H,
    7. Xie H,
    8. Fan Z
    : Subcutaneous nipple-sparing mastectomy and immediate breast reconstruction. Breast Care 7: 131-136, 2012.
    OpenUrlPubMed
  11. ↵
    1. Lecle‘re FM,
    2. Panet-Spallina J,
    3. Kolb F,
    4. Jarbay GR,
    5. Mazouni C,
    6. Leduey A,
    7. Leymarie N,
    8. Rimareix F
    : Nipple-sparing mastectomy and immediate reconstruction in ductal carcinoma in situ: a critical assessment with 41 patients. Aesth Plast Surg 38: 338-343, 2014.
    OpenUrlPubMed
  12. ↵
    1. Jensen JA,
    2. Orringer JS,
    3. Giuliano AE
    : Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years. Ann Surg Oncol 18: 1665-1670, 2011.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Ziogas D
    : Nipple sparing mastectomy: overcoming oncological outcomes challenges. Ann Surg Oncol 17: 323-324, 2010.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ward EM,
    2. DeSantis CE,
    3. Lin CC,
    4. Kramer JL,
    5. Jemal A,
    6. Kohler B,
    7. Brawley OW,
    8. Gansler T
    : Cancer statistics: breast cancer in situ. CA Cancer J Clin 65: 481-495, 2015.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Fortunato L,
    2. Loreti A,
    3. Andrich R,
    4. Costarelli L,
    5. Amini M,
    6. Farina M,
    7. Santini E,
    8. Vitelli CE
    : When mastectomy in needed: Is the nipple-sparing procedure a new standard with very few contraindications? J Surg Oncol 108: 207-212, 2013.
    OpenUrlPubMed
  16. ↵
    1. Lee KT,
    2. Mun GH
    : Comparison of one-stage vs. two-stage prosthesis-based breast reconstruction: a systematic review and meta-analysis. Am J Surg 2015: S0002-9610(15)00534-6. doi: 10.1016/j.amjsurg.2015.07.015, 2015.
  17. ↵
    1. Follacchio GA,
    2. Monteleone F,
    3. Anibaldi P,
    4. De Vincentis G,
    5. Iacobelli S,
    6. Merola R,
    7. D'Orazi V,
    8. Monti M,
    9. Pasta V
    : A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study. J Exp Clin Cancer Res 2015: 113.doi: 10.1186/s13046-015-0230-x, 2015.
    OpenUrl
  18. ↵
    1. Soluri A,
    2. Trotta C,
    3. Scopinaro F,
    4. Tofani A,
    5. D'Alessandria C,
    6. Pasta V,
    7. Stella S,
    8. Massari R
    : Radioisotope guided surgery with imaging probe, a hand-held high-resolution gamma camera. Nucl Instr Meth Phys Res A 583: 366-371, 2007.
    OpenUrl
  19. ↵
    1. Simmons RM,
    2. Brennan M,
    3. Christos P,
    4. King V,
    5. Osborne M
    : Analysis of nipple/areolar involvement with mastectomy: Can the areola be preserved? Ann Surg Oncol 9: 165-168, 2002.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Algaithy ZK1,
    2. Petit JY,
    3. Lohsiriwat V,
    4. Maisonneuve P,
    5. Rey PC,
    6. Baros N,
    7. Lai H,
    8. Mulas P,
    9. Barbalho DM,
    10. Veronesi P,
    11. Rietjens M
    : Nipple-sparing mastectomy: Can we predict the factors predicting necrosis? Eur J Surg Oncol 38: 125-129, 2012.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Pasta V,
    2. D'Orazi V,
    3. Sottile D,
    4. Del Vecchio L,
    5. Panunzi A,
    6. Urciuoli P
    : Breast Mondor's disease: Diagnosis and management of six new cases of this underestimated pathology. Phlebology 30: 564-568, 2015.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Carlson GW,
    2. Chu CK,
    3. Moyer HR,
    4. Duggal C,
    5. Losken A
    : Predictors of nipple ischemia after nipple-sparing mastectomy. Breast J 20: 69-73, 2014.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Pasta V,
    2. Mitri F,
    3. Amabile MI,
    4. Picardi N
    : Inflammatory breast cancer. Ann Ital Chir 77: 275-279, 2006.
    OpenUrlPubMed
  24. ↵
    1. Pasta V,
    2. Amabile MI,
    3. Bizzarri M,
    4. Monti M
    : Breast sarcoma in a pregnant patient. A case report. Ann Ital Chir, 2012: S2239253X12020178, 2012.
  25. ↵
    1. Pasta V,
    2. Monti M,
    3. Cialini M,
    4. Vergine M,
    5. Urciuoli P,
    6. Iacovelli A,
    7. Rea S,
    8. D'Orazi V
    : Primitive sarcoma of the breast: new insight on the proper surgical management. J Exp Clin Cancer Res 34: 72, 2015.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 36, Issue 2
February 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience
MARIA IDA AMABILE, MASSIMO MONTI, RAFFAELE MEROLA, FEDERICO FRUSONE, VALERIO D'ORAZI, VITTORIO PASTA
Anticancer Research Feb 2016, 36 (2) 779-783;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience
MARIA IDA AMABILE, MASSIMO MONTI, RAFFAELE MEROLA, FEDERICO FRUSONE, VALERIO D'ORAZI, VITTORIO PASTA
Anticancer Research Feb 2016, 36 (2) 779-783;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature
  • Google Scholar

More in this TOC Section

  • Whole-liver Palliative Radiotherapy Using SIB for Diffuse Liver Metastases: 3D-CRT versus 99mTc-GSA SPECT Image-guided VMAT
  • Real-world Analysis of Treatment Patterns, Clinical Outcomes, and Molecular Profiling in Advanced Biliary Tract Cancer
  • Post-progression Nutritional and Immune Status Determines Survival After First-line Chemotherapy in Unresectable Advanced Gastric Cancer
Show more Clinical Studies

Keywords

  • nipple-sparing mastectomy
  • non-invasive breast cancer
  • Breast reconstruction
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire